The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical cardiology"
DOI: 10.1002/clc.23807
Abstract: BACKGROUND The duration of beta-blocker therapy in patients without heart failure (HF) or left ventricular systolic dysfunction after acute myocardial infarction (AMI) is unclear. HYPOTHESIS Continuous beta-blocker therapy is associated with an improved prognosis. METHODS… read more here.
Keywords: beta blocker; continuous beta; blocker therapy;
β-Adrenergic blockade in patients with dementia and hip fracture is associated with decreased postoperative mortality
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Trauma and Emergency Surgery"
DOI: 10.1007/s00068-021-01723-y
Abstract: Dementia, present in 20% of hip fracture patients, is associated with an almost threefold increase in postoperative mortality risk. These patients have a substantially higher incidence of cardiovascular, respiratory, and cerebrovascular mortality after hip fracture… read more here.
Keywords: postoperative mortality; mortality; hip fracture; beta blocker ... See more keywords
Therapeutic effect of beta‐blocker in patients with traumatic brain injury: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Critical Care"
DOI: 10.1016/j.jcrc.2017.05.035
Abstract: Objective: &bgr;‐Blocker exposure has been shown to reduce mortality in traumatic brain injury (TBI); however, the efficacy of &bgr;‐blockers remains inconclusive. Therefore, a meta‐analysis was conducted in this paper to evaluate the safety and efficacy… read more here.
Keywords: bgr blocker; blocker; blocker therapy; meta analysis ... See more keywords
MO097BETA BLOCKER PREVENTS CARDIAC MOLECULAR AND MORPHOLOGICAL REMODELLING IN EXPERIMENTAL URAEMIA
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab106.006
Abstract: Fifty years of heart failure research has shown that pathological cardiac remodelling forms a vicious cycle with myocardial dysfunction leading to progressive heart failure (HF) [Circulation, 102 IV14-23, 2000]. Fetal gene induction is associated with… read more here.
Keywords: blocker; beta; cardiac remodelling; blocker therapy ... See more keywords
Preoperative β-Blocker Therapy and Stroke or Major Adverse Cardiac Events in Major Abdominal Surgery: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Anesthesiology"
DOI: 10.1097/aln.0000000000004404
Abstract: Background: Perioperative β-blocker therapy has been associated with increased risk of stroke. However, the association between β-blocker initiation before the day of surgery and the risk of stroke is unknown. The authors hypothesized there would… read more here.
Keywords: abdominal surgery; blocker therapy; blocker; major abdominal ... See more keywords
AB0383 Subclinical brain damage in patients with rheumatoid arthritis and its relationship to TNF blocker therapy
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2315
Abstract: Background RA is a chronic disease with a yet unclarified etiology, which causes the activation of pro-inflammatory pathways that bring about joint and systemic inflammations (1).In recent years, the pathophysiology of brain damage that can… read more here.
Keywords: blocker therapy; tnf blocker; therapy; brain damage ... See more keywords
Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Heart"
DOI: 10.1136/heartjnl-2016-310617
Abstract: Background Pregnancy is one of the biggest concerns for women with long QT syndrome (LQTS). Objectives This study investigated pregnancy-related arrhythmic risk and the efficacy and safety of β-blocker therapy for lethal ventricular arrhythmias in… read more here.
Keywords: risk; blocker therapy; pregnancy; group ... See more keywords
Abstract 4365866: Beta-Blocker Therapy After Acute Myocardial Infarction in Patients with Mildly Reduced or Preserved Ejection Fraction: An Updated Meta-Analysis
Sign Up to like & getrecommendations! Published in 2025 at "Circulation"
DOI: 10.1161/circ.152.suppl_3.4365866
Abstract: Background: Current guidelines recommend beta-blocker use after myocardial infarction (MI), however, Recent data has challenged the utility of beta-blockers in patients with preserved (LVEF>50%) or mildly reduced left ventricular ejection fraction (LVEF 40-50%) post the… read more here.
Keywords: blocker therapy; myocardial infarction; beta blocker; beta ... See more keywords
Beta receptor blocker therapy for the elderly in the COVID-19 era
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i23.8088
Abstract: When the coronavirus disease 2019 (COVID-19) pandemic spread globally from the Hubei region of China in December 2019, the impact on elderly people was particularly unfavorable. The mortality associated with severe acute respiratory syndrome coronavirus… read more here.
Keywords: beta; covid; beta blockers; blocker therapy ... See more keywords
Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy
Sign Up to like & getrecommendations! Published in 2024 at "Anatolian Journal of Cardiology"
DOI: 10.14744/anatoljcardiol.2023.3898
Abstract: Background: Hypertrophic cardiomyopathy (HCM) is a genetically inherited cardiac disorder with diverse clinical presentations. Adrenergic activity, primarily mediated through beta-adrenoceptors, plays a central role in the clinical course of HCM. Adrenergic stimulation increases cardiac contractility… read more here.
Keywords: blocker therapy; beta blocker; response; beta ... See more keywords
Association Between Early Oral β-Blocker Therapy and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction With Mild-Moderate Heart Failure: Findings From the CCC-ACS Project
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.828614
Abstract: Background There are limited data available on the impact of early (within 24 h of admission) β-blocker therapy on in-hospital outcomes of patients with ST-elevation myocardial infarction (STEMI) and mild-moderate acute heart failure. This study… read more here.
Keywords: heart failure; early oral; oral blocker; therapy ... See more keywords